Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Combined intraperitoneal and systemic chemotherapy as adjuvant or perioperative chemotherapy for patients with type 4 scirrhous gastric cancer: PHOENIX-GC2 trial.
Authors
Hironori Ishigami
Department of Chemotherapy, The University of Tokyo, Tokyo, Japan;
Hironori Ishigami , Takeshi Omori , Yasushi Tsuji , Hisashi Shinohara , Hiroshi Yabusaki , Daisuke Kobayashi , Daisuke Takahari , Hiroaki Hata , Tetsuya Kusumoto , Mitsuro Kanda , Koji Oba , Joji Kitayama , Yasuyuki Seto
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Trials in Progress Poster Session
Session Title
Trials in Progress Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Therapeutics
Clinical Trial Registration Number
jRCT2031200087
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr TPS477)
DOI
10.1200/JCO.2023.41.4_suppl.TPS477
Abstract #
TPS477
Poster Bd #
N12
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Safety and efficacy of intraperitoneal paclitaxel plus systemic FOLFOX for gastric cancer with peritoneal metastasis: Phase I results.
First Author: So Hyun Kang
Poster
2020 Gastrointestinal Cancers Symposium
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first‑line therapy in patients with locally advanced unresectable or metastatic gastric or gastroesophageal junction (G/GEJ) adenocarcinoma.
First Author: Rui-hua Xu
Poster
2018 ASCO Annual Meeting
Iconic: Peri-operative immuno-chemotherapy in operable oesophageal and gastric cancer.
First Author: Sonia Mansukhani
Poster
2018 Gastrointestinal Cancers Symposium
Extended outcomes of intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastases.
First Author: Dexter Yak Seng Chan